Peculiarità degli ospedali pubblici e riflessi sul governo aziendale: verso una governance partecipativa.

Anteprima

La letteratura sulle aziende sanitarie pubbliche ha animato il dibattito accademico degli ultimi decenni ma ha trascurato l’esame dei fattori da cui derivano i modelli di hospital governance. Alla luce delle peculiarità degli ospedali pubblici, lo studio esamina i vantaggi e i limiti dei modelli di governo ospedaliero in essere e propone uno schema di governo tagliato su tali caratteristiche. In particolare, la ricerca mostra come l’elevata stakeholder sensitivity delle aziende ospedaliere pubbliche dovrebbe riflettersi in modelli di governance partecipativi in cui la rendicontazione assume una funzione chiave. In tal modo, lo studio costituisce un riferimento per le future ricerche sul tema e fornisce un’utile guida per i policy maker.

____________________________________

Over the last decades, literature on public healthcare organizations has extensively explored hospital governance but has not examined its driving factors. Relying on the characteristics of public hospitals, the research examines the advantages and drawbacks of the existing hospital governance schemas and proposes a governance model customized on the above mentioned peculiarities. More specifically, it shows that the high stakeholder sensitivity of public hospitals should lead to participatory governance models where accountability represents the main governance function. Thereby, the study has implications for both academics and policy makers.

_

Key words: Public Hospital, Hospital Governance

Bibliografia
  1. Anessi Pessina E., Cantù E. (2006), “Whither managerialism in the Italian National Health Service?”, International Journal of Planning and Management, 21(4), pp. 327-355.
  2. baRnett p., peRkins R., poWell M. (2001), “On a hiding to nothing? Assessing the corporate governance of hospital and health services in New Zealand 1993-1998”, International Journal of Health Planning and Management, 16(2), pp. 139-154.
  3. beeckun R., stedhaM y., young g. (1998), “Board characteristics, managerial controls and corporate strategy: A study of U.S. hospitals”, Journal of Management, 24, pp. 3-19.
  4. bennington l. (2010), “Review of the corporate and healthcare governance literature”, Journal of Management & Organization, 16(2), pp. 314-333.
  5. boekeR W., goodstein J. (1991), “Organizational performance and adaptation: Effects of environment and performance changes in board composition”, Academy of Management Journal, 34, pp. 805-826.
  6. boRgonoVi e. (1996), Principi e sistemi aziendali per le amministrazioni pubbliche, Milano: EGEA.
  7. bRickley J.a., Van hoRn l. (2002), “Managerial incentives in nonprofit organizations: Evidence from hospitals”, Journal of Law and Economics, 45(1), pp. 227–249.
  8. capasso a., pascaRella G. (a cura di) (2011), L’azienda sanitaria. Innovazione tecnologica, evoluzione organizzativa e governo clinico, Milano: Franco Angeli.
  9. cassano R. (2013), Accountability e stakeholder relationship nelle aziende pubbliche, Milano: Franco Angeli.
  10. coda V. (2000), “Per un buon governo delle aziende sanitarie pubbliche”, Azienda Pubblica 2/3, pp.151-158. cuccuRullo c. (2003), Il management strategico nelle aziende sanitarie pubbliche, Milano: McGrawHill.
  11. cuccuRullo c., lega F. (2013), “Effective strategizing practices in pluralistic settings: The case of Academic Medical Centers”, Journal of Management and Governance, 17(3), pp. 609-629.
  12. de pietRo c., pRenestini a. (2008), “Governance professionale nelle aziende sanitarie pubbliche: il ruolo del Collegio di direzione e del Consiglio dei sanitari”, in Anessi Pessina E., Cantù E. (a cura di) Rapporto OASI 2008. L’aziendalizzazione della sanità in Italia, Milano: EGEA.
  13. del Vecchio M. (2006), “Nuove tendenze nelle strutture di governo: interpretazioni e riflessioni a margine di un documento della Regione Emilia Romagna”, in Anessi Pessina E., Cantù E. (a cura di), Rapporto OASI 2006. L’aziendalizzazione della sanità in Italia, Milano: EGEA.
  14. denis J.l., laMothe l., langley a. (2001), “The dynamics of collective leadership and strategic change in pluralistic organizations”, Academy of Management Journal, 44(4), pp. 809-837.
  15. eeckloo k., delesie l., Vleugels a. (2007), “Where is the pilot? The changing shapes of governance in the European hospital sector”, The Journal of the Royal Society for the Promotion of Health, 127(2), pp. 78-86.
  16. eeckloo k., Van heRck g., Van hulle c. and Vleugels a. (2004) “From corporate governance to hospital governance. Authority, transparency and accountability of Belgian non-profit hospitals’ board and management”, Health policy, 68(1), pp. 1-15.
  17. eldenbuRg l., heRMalin b.e., Weisbach M.s., Wosinska M. (2004), “Governance, performance objectives and organizational form: Evidence from hospitals”, Journal of Corporate Finance, 10(4), pp. 527-548.
  18. Flannigan a., poWeR p. (2008), “Health Care Governance: Introduction”, Australian Health Review, 32(1), pp. 7-9. gioVannelli l., (2016), “Assetti di governance ed equilibri di potere nel governo delle aziende sanitarie”, in Marinò L. (a cura di), In Modelli di management nel settore sanitario, Torino: Giappichelli.
  19. gloubeRMan s., MintzbeRg h. (2001), “Managing the care of health and the cure of disease. Part II: Integration”, Health Care Management Review, 26(2), pp. 70-84.
  20. goRsky M. (2008), “Community involvement in hospital governance in Britain: Evidence from before the National Health Service”, International Journal of Health Services Planning Administration Evaluation, 38(4), pp. 751-771.
  21. gRant R.M. (1996), “Toward a knowledge-based theory of the firm”, Strategic Management Journal, 17(S2), pp. 109-122.
  22. gReenhalgh t., huMphRey c., WoodaRd F. (a cura di) (2010), User involvement in health care, Hoboken, NJ: John Wiley & Sons.
  23. hiRigoyen g., laoueR R. (2013), “Convergence of corporate and public governance: insights from board process view”, Sage Open, 3(2), pp. 1-8.
  24. hood c. (1995), “The ‘New Public Management’ in the 1980s: Variations on a Theme”, Accounting, Organizations and Society, 20(2), pp. 93-109.
  25. huse M. (2007), Boards, governance and value creation. The human side of corporate governance, New York: Cambridge University Press.
  26. Jannelli R. (2014), Il governo delle aziende sanitarie ed ospedaliere. Problematiche di programmazione, rendicontazione e controllo, Milano: Franco Angeli.
  27. kiRkpatRick i., Vallascas F., VeRonesi g. (2017), “Business experts on public sector boards: what do they contribute?”, Public Administration Review.
  28. kuhlMann e., annandale e. (2012), “Researching transformations in healthcare services and policy in international perspective: An introduction”, Current Sociology, 60(4), pp. 401-414.
  29. laoueR R. (2011), “Physicians in management: a case study of their role in the governance structures in the French hospital boardroom”, The International Journal of Clinical Leadership, 17, pp. 103-109.
  30. Macleod d., claRke n. (2009), Engaging for success: Enhancing performance through employee engagement, London: Crown.
  31. MaRtin g.p. (2011), “The third sector, user involvement and public service reform: A case study in the co-governance of health service provision”, Public Administration, 89(3), pp. 909-932.
  32. Mattei p. (2006), “The enterprise formula, new public management and the Italian health care system: remedy or contagion?”, Public Administration, 84(4), pp. 1007-1027.
  33. Mcdonagh k.J., uMbdenstock R.J. (2006), “Hospital governing boards: A study of their effectiveness in relation to organizational performance”, Journal of Healthcare Management, 51(6), pp. 377-389.
  34. MuelleR F., haRVey, c., hoWoRth c. (2003), “The contestation of archetypes: Negotiating scripts in a UK hospital trust board”, Journal of Management Studies, 40, pp. 1971-1995.
  35. nhs White papeR (1998), A First Class Service: Quality in the New NHS (White Paper), Department of Health: London.
  36. nunes R., Rego g., bRandão c. (2007), “The rise of independent regulation in health care”, Health Care Analysis, 15(3), pp. 169-177.
  37. pollitt c., bouckaeRt g. (2002), La riforma del management pubblico, Milano: Università Bocconi Editore.
  38. poWeRs t.l., bendall d. (2004), “Improving health outcomes through patient empowerment”, Journal of Hospital Marketing & Public Relations, 15(1), pp. 45-59.
  39. RaMsay a., Fulop n., FResko a., Rubenstein s. (2013), The Healthy NHS board 2013. Review of guidance and research evidence, Londra: NHS Leadership Academy.
  40. saita M. (2007), Governance ed economicità nelle aziende sanitarie, Milano: Il Sole 24 Ore Sanità.
  41. saltMan R., duRán a., dubois h. (a cura di) (2011), Governing public hospitals. Reform strategies and the movement towards institutional autonomy, Londra: Observatory Studies Series N. 25.
  42. saRto F. (2015), La governance delle aziende ospedaliere pubbliche. Il ruolo del medico-manager, Padova: CEDAM.
  43. saRto F., cuccuRullo c., aRia M. (2014), “Exploring healthcare governance literature: systematic review and paths for future research”, Mecosan, 23(91), pp. 61-80.
  44. saRto F., VeRonesi g. (2016), “Clinical leadership and hospital performance: Assessing the evidence base”, BMC Health Services Research, 16(S2), pp. 85-97.
  45. saRto F., VeRonesi g., kiRkpatRick i., cuccuRullo c. (2015), “Exploring regionalism in public management reforms: The case of the Italian hospital sector”, Policy & Politics, 44(4), pp. 525-545.
  46. schRaMko t.d. (2007), “The characteristics of an effective physician-hospital working relationship: an exploratory study”, Health Care Analysis, 15(2), pp. 91-105.
  47. stolzenbeRg e.a. (2000), “Governance change for public hospitals”, Journal of Healthcare Management, 45(5), pp. 347350.
  48. toth F. (2010), “Healthcare policies over the last 20 years: Reforms and counter-reforms”, Health Policy, 95(1), p. 82-89.
  49. VeRonesi g., keasey k. (2015), “Patient and public participation in the English NHS: An assessment of experimental implementation processes”, Public Management Review, 17(4), pp. 543-564.
  50. VeRonesi g., kiRkpatRick i., Vallascas F. (2013), “Clinicians on the board: What difference does it make?”, Social science & medicine, 77, pp. 147-155.
  51. Viganò e. (2000), Azienda. Contributi per un rinnovato concetto generale, Padova: CEDAM.
  52. Vining a.R., WeiMeR d. (2005), “Economic perspective on public organizations”, in Ferlie E, Lynn L.E. Pollitt C. (a cura di), The Oxford Handbook of Public Management, Oxford: Oxford University Press.
  53. Vinot d. (2014), “Transforming hospital management à la francaise”, International Journal of Public Sector Management, 27(5), pp. 406-416.
  54. Von noRdenFlycht a. (2010), “What is a professional service firm? Toward a theory and taxonomy of knowledge-intensive firms”, Academy of Management Review, 35(1), pp. 155-174.
  55. Weil t.p. (2003), “Governance in a period of strategic change in U.S. healthcare”, The International Journal of Health Planning and Management, 18(3), pp. 247-265.
  56. WRight J.s.F., deMpsteR p.g., keen J., allen p., hutchings a. (2012), “The new governance arrangements for NHS Foundation Trust hospitals: Reframing governors as meta-regulators”, Public Administration, 90(2), pp. 351-369.
  57. zattoni a. (2004), Il governo economico delle imprese, Milano: EGEA